Phase II Study of Gemcitabine in Patients With Advanced Stage Marginal Zone B-cell Lymphoma
Phase of Trial: Phase II
Latest Information Update: 19 Feb 2016
At a glance
- Drugs Gemcitabine (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 12 May 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 01 Oct 2006 New trial record.